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Autosomal dominant polycystic kidney disease, a leading
cause of end-stage renal disease in adults, is characterized by
progressive focal cyst formation in the kidney. Embryonic
lethality of Pkd1-targeted mice limits the use of these mice.
Here we developed a floxed allele of Pkd1 exons 2–6. Global
deletion mutants developed polyhydramnios, hydrops fetalis,
polycystic kidney and pancreatic disease. Somatic Pkd1
inactivation in the kidney was achieved by crossing Pkd1flox
mice with transgenic mice expressing Cre controlled by a c-
glutamyltranspeptidase promoter. These mutants developed
cysts in both proximal and distal nephron segments and
survived for about 4 weeks. Somatic loss of heterozygosity
was shown in a reporter mouse strain to cause cystogenesis.
Some cysts in young mice are positive for multiple tubular
markers and a mesenchymal marker, suggesting a delay in
tubular epithelial differentiation. A higher cell proliferation
rate was observed in distal nephron segments probably
accounting for the faster growth rate of distal cysts. Although
we observed an overall increase in apoptosis in cystic
kidneys, there was no difference between proximal or distal
nephron segments. We also found increased cyclic AMP,
aquaporin 2 and vasopressin type 2 receptor mRNA levels,
and apical membrane translocation of aquaporin 2 in cystic
kidneys, all of which may contribute to the differential cyst
growth rate observed. The accelerated polycystic kidney
phenotype of these mice provides an excellent model for
studying molecular pathways of cystogenesis and to test
therapeutic strategies.
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Autosomal dominant polycystic kidney disease (ADPKD) is
the most common inherited kidney disorder, with an average
occurrence of 1:500–1:1000 people and accounting for 45%
of patients with end-stage renal failure in Europe and the
United States.1 ADPKD is characterized by focal formation of
multiple cysts in the kidneys, in the liver in B50% of cases,
and much less frequently in the pancreas. Cardiovascular
abnormalities, including hypertension, mitral valve prolapse,
and intracranial aneurysms, are also often recognized.
ADPKD is caused by mutations in PKD1 and PKD2 genes
encoding polycystin-1 and 2 (PC1 and PC2). PC1 and PC2
function as a mechanosensitive receptor-channel protein
complex and mediate G-protein and Ca2þ signaling.2,3
Every cell in an ADPKD patient carries an inherited
mutation in either the PKD1 or PKD2 gene, yet focal cysts
form in only B5% of nephrons. Reeders4 proposed a ‘two-
hit’ hypothesis to explain the focal nature of cyst develop-
ment: a germline mutation in one of the two copies (‘alleles’)
of, for example, PKD1 in a given cell is not sufficient to alter
the phenotype of that cell and initiate cyst formation because
the second allele is functioning normally. Cystogenesis occurs
when a somatic mutation knocks out the ‘normal’ allele so
that one allele has a germline mutation (‘first hit’), the other
has a somatic mutation (‘second hit’), neither allele is
functional, and no PC function remains. A cyst then forms
through proliferation of the cell that has received two ‘hits.’
The hypothesis predicts that the number of cysts will increase
during life as the somatic or second hits accumulate. This
hypothesis has since received support from studies in renal
cysts5 and liver cysts6 using human tissues with ADPKD.
Using gene targeting, a powerful tool for studying gene fun-
ction in vivo, inactivation of mouse Pkd1 and Pkd2, including
Pkd1del34,7 Pkd1del43–45,8 Pkd1null,9 Pkd1del17–21bgeo,10 and
Pkd2,11 resulted in similar phenotypes. In homozygotes,
kidney development proceeds normally until embryonic day
15.5, at which time point cystic dilatation of renal tubules is
evident, as is cystic degeneration in the pancreas,7,9 which is
consistent with the ‘two-hit’ hypothesis. All homozygous
mice develop polyhydramnios and hydrops fetalis.7,9 Whereas
defects in skeletal development have been described for Pkd1
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mutants,9,10 Pkd2-targeted mice develop laterality defects.12
Mice with a heterozygous mutation of Pkd1, however, only
develop scattered renal and hepatic cysts late in life.13 The
slow rate of cyst development in Pkd1 heterozygotes was
hypothesized to be the result of the slow development of
somatic second hits in mice.13
Conventional gene targeting has provided us valuable
clues about the role of PC1 and PC2 in development;7–11
however, it has been less effective in elucidating the
physiological or pathophysiological processes that occur later
in life for the following reasons. First, inactivation of a
developmentally important gene, such as Pkd1, resulted in
perinatal lethality, excluding the possibility of functional
analysis in adult life. Second, conventional gene-targeting
technology is unable to introduce mutations in a time- and
location-specific manner.
The Cre-loxP site-specific recombination system has been
used successfully to produce mice with tissue- and time-
specific deletions.14 By crossing ‘floxed’ mice with transgenic
mice expressing the Cre recombinase in the desired time-
and/or tissue-specific manner, one can achieve conditional
gene inactivation. This approach was used recently to develop
a conditional model in which somatic Pkd1 inactivation was
under the control of MMTV.Cre.15 Although mice were
created successfully, only scattered cysts were observed in
mice at 20 weeks of age. The lack of a polycystic kidney
phenotype and the length of time needed to develop scattered
cysts limit the usefulness of this model for phenotypic and
experimental studies of ADPKD.
In this study, we developed two new Pkd1-knockout
mouse models simultaneously with using Cre-loxP technol-
ogy. These mice develop striking polycystic kidney pathology.
Disruption of the Pkd1 gene in a time- and tissue-specific
manner yielded direct evidence supporting the two-hit
hypothesis.
RESULTS
Generation of the Pkd1 conditional knockout mouse
A Pkd1 conditional construct was designed to study the
effects of loss of PC function after birth. A loxP-flanked
neomycin selection cassette was inserted into the EcoRI site
located 1.2 kb upstream of exon 2, and a third loxP site was
placed in intron 6 (Figure 1a). Homologous recombinants
were identified by Southern blotting using a 50 probe. Two
independently targeted embryonic stem cell clones were
injected into C57BL/6J blastocysts. The resulting chimeric
mice, with 490% of the agouti coat, were crossed with
C57BL/6 and BALB/c mice to produce F1 progeny with
germline transmission.
The offspring with germline transmission were crossed
with mice carrying a germline Cre transgene (Prm.Cre).
The Cre recombinase targets random combinations of any of
the three available loxP sites and results in four possible
recombinations, two of which are desirable events (Figure
1b). One leads to complete deletion of the region between the
two outlying loxP sites, creating a conventional knockout,
dubbed ‘Pkd1del2–6’. The other leads to removal of only the
neomycin cassette, which creates what is commonly called a
‘floxed’ allele. The latter is used for generating conditional
knockouts by crossing with a transgenic mouse expressing a
tissue-specific Cre recombinase.
The design of the Pkd1 conditional targeted construct was
expected to result in deletion of exons 2 through 6, which is
an in-frame deletion. Reverse transcriptase-polymerase chain
reaction on RNA isolated from kidneys with primers specific
for exons 1(KO-F), 2 (F27), 5(R37), 10 (R104/F201), and
11(R201) (Figure 1a, ‘floxed’ allele) showed that the Pkd1
transcript present in our conventional mutants lacks not only
exons 2 through 6, but also exon 7 (Figure 1c). This
alternative splicing event resulted in a transcript with a stop
codon at the beginning of exon 8 (Figure 1c).
To investigate whether these mutant transcripts produced
stable products, we examined the expression levels of the
Pkd1 protein in kidney lysates from Pkd1del2–6 homozygotes
and heterozygotes, and compared them with that of wild-
type littermates using a monoclonal antibody, 7e12, directed
against the N-terminal region of PC1. A band of B460 kDa
was detected in both the wild-type and heterozygous
newborn kidneys, but it was absent in homozygous Pkd1del2–6
mutants (Figure 1d, left). PC2 appears to be expressed
normally, although protein levels in the Pkd1del2–6 homo-
zygotes appeared to be slightly decreased (Figure 1d, right).
PC1 and PC2 directly interact through the putative coiled-
coil domains in their C-termini.16
It has been reported that the rate of cell proliferation
increases in ADPKD kidney epithelia, which may be a result
of decrease of p21 in polycystic kidneys.17 Similar to our
Pkd1null/null mutants,18 we found an decrease in the
expression of cyclin-dependent kinase inhibitor p21 in the
kidneys of newborn Pkd1del2–6/del2–6 mice, as compared with
that in their respective wild-type littermates (Figure 1e).
However, p27 expression in homozygous Pkd1del2–6 kidneys
was not altered significantly (Figure 1e).
Rapid progression of kidney cysts in homozygous
Pkd1del2–6 pups
To investigate whether deletion of exons 2–6 of the Pkd1 gene
would result in functional inactivation of PC1, we intercrossed
Pkd1del2–6 mice to produce homozygous Pkd1del2–6/del2–6
offspring. From our previous studies, we know that
homozygous inactivation of Pkd1 results in embryonic
lethality; we therefore expected that Pkd1del2–6/del2–6 offspring
were unlikely to be viable. To our surprise, B50% of the
homozygous Pkd1del2–6/del2–6 mice survived to birth (Table 1).
The survival rate for mice homozygous for Pkd1del2–6 was
much higher than that of mice homozygous for the
previously described Pkd1null mutants.9 Virtually all homo-
zygous Pkd1del2–6 pups died on the day of birth, whereas
homozygous Pkd1null mutants died as early as E13.5, with a
peak between E14.5 and E16.5,9 although in very rare cases,
they survived longer. Pkd1del2–6/del2–6 mutants (Figure 2b)
displayed a comparable cystic phenotype as Pkd1null/null
Kidney International (2008) 73, 1394–1405 1395
PG Starremans et al.: A conditional mouse model for polycystic kidney disease o r i g i n a l a r t i c l e
mutants (Figure 2c). A large percentage of glomeruli
also develop cysts in both Pkd1del2–6/del2–6 (Figure 2e) and
Pkd1null/null (Figure 2f) homozygotes.
Timed pregnancies (Table 2) were set up, and 25 Pkd1del2–6
homozygotes were examined histologically for renal cystic
lesions. At E15 and E17, the cyst size in Pkd1del2–6 kidneys was
comparable to that of Pkd1null kidneys at the respective
stages. The homozygous Pkd1del2–6 pups surviving to birth
exhibited the same phenotype as documented previously for
other Pkd1 homozygous mutations, with polyhydramnios
and systemic edema.7,9 Onset of the cystic phenotype in
Pkd1del2–6 homozygous embryos occurred at the same stage
(E15.5) as reported for the Pkd1del34 and Pkd1null mutants7,9
(data not shown).
Somatic inactivation of the normal allele of Pkd1 and the
two-hit hypothesis
To achieve conditional inactivation of Pkd1 in kidney, we
bred our Pkd1flox mice with a transgenic mouse in which Cre
expression was driven by a promoter fragment of g-
glutamyltranspeptidase (gGt). gGt is expressed and regulated
in a tissue-specific manner, and is known to be present in bile
ducts, kidney, intestine, and other organs involved in
secretion. The gGt.Cre transgene is known to be expressed
in the kidney proximal tubule.19 To evaluate the effects of the
somatic inactivation of Pkd1 and the role of compound
heterozygous mutations on cyst formation, we crossed
gGt.Cre:Pkd1þ /flox with Pkd1null/þ mice to produce
gGt.Cre:Pkd1null/flox offspring. The expected Mendelian ratios
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Figure 1 | Generation of the Pkd1 conditional targeted mice. (a) Structure of the wild-type Pkd1 allele and the targeting strategy
resulting in ‘floxed’ exons 2–6 preceded by a ‘floxed’ neomycin cassette. Restriction sites: A, AvrII; Bm, BamHI; Nd, NdeI; Ri, EcoRI; S, SpeI (b)
The two desired recombination events after expression of Cre out of four possible recombinations. Genotyping primers (KO-F/R104,
F27-R37, F201-R201) are indicated below the ‘floxed’ allele. (c) Reverse transcriptase-polymerase chain reactions showing the splicing events
for exons 2–5 (F27F37), exon 10–11 (F201þ R201), and exon 1–9 (KO-FR104) in wild-type, heterozygous, and homozygous mice. Shown
below is the sequence of the Pkd1 transcript after recombination, resulting in a stop codon in exon 8. (d) Immunoblots of wild type,
heterozygote, and homozygote kidney lysates for PC1 (left blot) and PC2 (right blot). (e) Levels of p21 and p27 expression in kidneys from
wild type, heterozygous, and homozygous Pkd12–6 mice. Actin was used as a control.
Table 1 | Newborn survival rate for homozygous Pkd1del2-6/del2-6 or Pkd1null/null mice
Mutation No. of litters No. of pups No. of / Expected no. of / Survival (%)
C57/B6 null 17 143 4 36 11.1
C57/B6 129SvEv Del2–6 46 323 41 81 50.6
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were observed for live-born progeny of all possible genotypes,
indicating that no embryos in any group died during
embryogenesis. Although no cystic phenotype was observed
in heterozygous mice with gGt.Cre:Pkd1þ /null (Figure 3a) or
gGt.Cre:Pkd1þ /flox (Figure 3b) genotype, gGt.Cre:Pkd1null/flox
mice had severe cystic lesions at 10 days (Figure 3c), with
progressive increase in severity over time (Figure 3d).
However, glomerular cysts seen in Pkd1null/null and
Pkd1del2–6/del2–6 mice were not observed in gGt.Cre:Pkd1null/flox
mice (Figure 3e) even at 26 days (Figure 3f). Most
gGt.Cre:Pkd1null/flox offspring died before 1 month of age.
These data confirm the ‘two-hit’ theory that somatic
inactivation of the second Pkd1 allele in mice carrying a
heterozygous germline mutation leads to a dominant PKD
phenotype.
Characterization of cyst origins in cGt-Cre:Pkd1flox/flox
To further characterize the nature of the cysts, we fixed and
sectioned kidneys from 10-day-old gGt.Cre:Pkd1flox/flox
(Figure 4d–f) mice and their Pkd1flox/flox littermates lacking
Cre (Figure 4a–c). Histological analysis showed an obvious
cystic phenotype in the kidneys of Cre-carrying animals
(Figure 4d). We subsequently stained these sections with
tubular markers Lotus tetragonolobus agglutinin (LTA)
(Figure 4b and e; Figure S1a, c, d, and f), Dolichos biflorus
agglutinin (DBA) (Figure 4c and f; Figure S1b, c, g, and i),
and anti-Tamm–Horsfall protein (THP) (Figure S1e, f, h, and
i), which selectively stain the proximal tubule, the collecting
tubule/duct segments, or the thick ascending limbs of Henle’s
loop, to identify the tubular origin of a particular cyst. We
found that cysts in gGt-Cre:Pkd1flox/flox kidneys can originate
from either proximal or distal tubular segments, with the
larger cysts being mainly distal rather than proximal in origin
(Figure 4c; Figure S1a–i). These findings expand upon the
observation that gGt.Cre is expressed in mouse kidney cortex,
since specific tubular segments were not characterized in that
study.19
To determine whether collecting tubule cysts were
secondary to proximal tubule cysts, or were the result of
Cre expression in these tubules, we generated gGt.Cre:Ds-
Red:Pkd1flox/flox mice by introducing a DsRed reporter
transgene into the gGt.Cre:Pkd1flox/flox background. The
DsRed transgene is preceded by a floxed sequence that
prevents its expression. Excision of the floxed sequence by a
Cre recombinase is required for constitutional expression of
fluorescent protein. Presence of DsRed could be clearly
detected in most cortical tubule segments in frozen tissue
sections from control gGt.Cre:DsRed:Pkd1flox/þ mice (not
shown). Because of the poor morphology of frozen cystic
kidney sections from gGt.Cre:DsRed:Pkd1flox/flox mice, we
stained formalin-fixed, paraffin-embedded, kidney sections
with an fluorescein isothiocyanate-coupled anti-red fluores-
cent protein (RFP) antibody. DsRed protein (green) could be
detected in the epithelial cells of cysts derived from the
proximal tubule (Figure 5a–c), the thick ascending limb of
Henle’s loop (TAL) (Figure 5d–f), and the collecting tubules
(Figure 5g–i). These results indicate that the gGt promoter
NB
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e19.5
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Pkd1del2-6/del2-6
e19.5
Pkd1null/null
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d e f
Figure 2 | Phenotype of a new Pkd1 mutation lacking a neomycin cassette. Histological comparison of kidney phenotypes in
hematoxylin–eosin-stained sections (original magnification  25) from newborn wild-type (a) newborn Pkd1del2–6/del2–6 (b), and a rare
Pkd1null/null pup surviving until E19.5 (c). (d–f) Glomeruli (original magnification  400) from the same sections used in (a–c) showing cyst
formation in glomeruli from (e) newborn Pkd1del2–6/del2–6 and (f) Pkd1null/null.
Table 2 | Pkd1del2-6/del2-6 timed pregnancies
Stage No. of pups No. of / Expected / Survival (%)
E15.5 days 73 20 18 100
E17.5 days 21 5 5 100
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fragment is active in both proximal and distal nephron
segments.
Distal tubular cysts progress at a faster rate than cysts of
proximal tubule origin
Most of the larger cysts were located in the more medullary
regions of the gGt.Cre:Pkd1flox/flox kidneys. We therefore
investigated the tubular origins of these cysts in relationship
to their size and progression rate. We co-stained kidney
sections of 16 different animals ranging in age from 3 to 26
days for proximal (LTA) and distal (collecting tubule/ducts)
(DBA) tubular markers using directly labeled lectins to avoid
the cross-reactions of secondary detection methods. Using
fluorescence microscopy, we determined the number and
origin of the cysts in at least three fields on two separate
sections per animal. The relative cyst sizes were subsequently
measured with Image-Pro Plus software. The rate of cyst
enlargement in relationship with their origin (either proximal
or distal) was documented and compared. Interestingly, the
size of distal tubule cysts increased much more than the
proximal tubule cysts (Figure 6a). Furthermore, after 12–15
days of age, the proximal tubule cysts did not increase in size
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10 days
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10 days
d
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γGT.Cre:Pkd1flox/null fb γGT.Cre:Pkd1 flox/+
42 days
42 days
26 days
γGT.Cre:Pkd1flox/null
Figure 3 | Somatic inactivation of a Pkd1 allele. Histological comparison of kidney phenotype in hematoxylin–eosin-stained sections from
gGt.Cre:Pkd1null/þ (a) and gGt.Cre:Pkd1flox/þ (b) heterozygote control mice (42 days old), showing no signs of cysts versus gGt.Cre:Pkd1flox/null
compound heterozygotes at 10 days (c) or 26 days (d) of age with a clear progressive cystic kidney phenotype (original magnification 25 ).
(e, f) Original magnification  400 showing absence of glomerular cysts in gGt.Cre:Pkd1flox/null kidneys at 10 (e) or 26 days (f).
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Figure 4 | Effects of cGt.Cre as the inducer of cyst formation. Comparison of kidney sections of 10-day-old Pkd1flox/flox controls (a–c) and
gGt.Cre:Pkd1flox/flox-knockout mice (d–f). (a, d) Hematoxylin–eosin (original magnification  25) (b, e) LTA staining (green) of control and
knockout sections showing (dilated) tubules and cysts of proximal tubule origin. (c, f) DBA staining (red) of control and knockout sections
showing (dilated) tubules and cysts of distal/collecting tubule origin. Asterisks indicate cysts (blue, DAPI; original magnification  100).
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and either regressed or completely disappeared, leaving
mostly large cysts of distal tubule origin, which greatly
increased the DBA:LTA cyst size ratio toB70-fold (Figure 6b).
A decrease in the total number of cysts was also noted,
whereas the number of cysts of different origin per observed
field remained largely constant, with an equal number of
cysts expressing proximal or distal tubule markers. This
decrease in the total number of cysts, combined with an
overall increase in kidney volume, would thus account for the
increase in the size of the individual distal tubular cysts
(Figure 6c). Additionally, in animals younger than 12 days of
age, up to 20% of cysts double labeled for DBA and LTA
(Figure 6d). In older animals, however, no cysts expressed
more than one marker.
The role of apoptosis and cell proliferation in cyst growth
To determine the role of apoptosis in the differential growth
rates of cysts, we performed terminal uridine deoxynucleo-
tidyl transferase dUTP nick-end labeling (TUNEL) staining
on kidney sections from both cystic and control mice at 3, 5,
7, 13, 15, 23, and 26 days of age. At all time points
investigated, normal controls (Figure S2a–c) showed little or
no evidence of apoptosis, whereas many TUNEL-positive
cells could be observed in their cystic littermates (Figure S2d–f).
However, no differences were observed between cysts in
cortex or medulla of the kidney.
Since TUNEL staining detects breaks or ‘nicks’ in double-
stranded DNA that can arise from sources other than
apoptosis, we used a complementary assay for apoptosis, by
detecting the cleavage of caspase 3. We co-stained kidney
sections from 2-day-old cystic mice (Figure 7a–l) and their
healthy littermates (Figure 7m–r) with an antibody to cleaved
caspase 3 and a tubular marker, either LTA (Figure 7a–c, g–i
and m–o) or DBA (Figure 7d–f, j–l and p–r). Both normal-
looking tubules and cysts in gGt.Cre:Pkd1flox/flox mice showed
increased number of cells positive for cleaved caspase 3,
indicating commitment to apoptosis. This increase, however,
is similar between tubules and cysts of either proximal or
distal origins. In contrast, cleaved caspase 3 was not detected
in the normal kidneys.
To investigate the contribution of cell proliferation in the
differential growth rates of cysts, we used kidney sections
from 2-day-old cystic mice (Figure 8a–f) and their healthy
littermates (Figure 8g–l), and co-stained for proliferating-cell
nuclear antigen with either LTA (Figure 8a–c, g–i) or DBA
(Figure 8d–f, j–l). We observed high levels of proliferation in
the nephrogenic zone and outer medulla, where elongation of
the Henle’s loop occurs,20 and lower levels of proliferation in
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Figure 5 | cGt.Cre is active in cysts of both proximal and distal tubule origin in cGt.Cre:DsRed:Pkd1flox/flox mouse kidneys at 27 days
of age. (a–c) Co-staining for DsRed and LTA (b) indicating expression of the Cre recombinase in cysts (*) of proximal tubule origin (c).
(d–f) Co-staining for DsRed and THP (e) indicating expression of the Cre recombinase in cysts (*) derived from the thick ascending limb of
Henle’s loop (f). (g–i) Co-staining for DsRed and DBA (h) indicating expression of the Cre recombinase in cysts (*) of distal/collecting tubule
origin (i) (blue, DAPI; original magnification  400).
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Figure 6 | Cysts of proximal and distal origin develop at different rates. (a) Average progression of cyst size in five age groups.
Each group included four animals. The average cyst size of all cysts is compared with that of cysts of either distal or proximal tubule origin.
A total number ofB1100 cysts were observed. (b) Plot of the ratio of DBA:LTA cyst size in five age groups. (c) Graph showing the average
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gGt.Cre:Pkd1flox/flox animal stained for LTA (green) and DBA (red) showing (dilated) tubules positive for both tubular markers (not seen in
wild-type littermates), implying lack of terminal maturation.
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original magnification  1000; cysts indicated by ‘Cy’, tubules indicated by ‘T’).
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tubules positive for either LTA or DBA in wild-type
littermates. In cystic kidneys, high levels of proliferation
were seen in DBA-positive tubules (Figure 8d–f and j–l), in
addition to the nephrogenic zone. No difference in
proliferation was seen in LTA-positive tubules between
wild-type and cystic kidneys (Figure 8a–c and g–i).
cAMP and cystogenesis
Changes in intracellular cAMP level could lead to changes in
transcription and protein expression of cAMP-responsive
proteins such as aquaporin 2 (AQP2) and the vasopressin V2
receptor (V2R). Moreover, AQP2 is known to translocate
from the sub-apical domain to the apical membrane in
response to increase in cAMP level. Therefore, we co-stained
kidney sections from cystic mice with AQP2 and LTA (Figure
9a–c), or DBA (Figure 9d–f). Whereas AQP2 was located
intracellularly in normal-looking tubules (Figure 9b and c,
arrowhead), it was found in the apical membrane of large
DBA-positive cysts (Figure 9b and c, arrows). No AQP2
signal was detected in LTA-positive cysts (Figure 9a–c,
asterisk). We also measured cAMP levels in kidneys from
both cystic animals and wild-type littermates, which revealed
20-fold increase in cAMP levels in cystic kidneys when
compared with those in wild-type kidneys (Figure 9g). Using
real-time PCR, we found a fivefold increase for AQP2, and a
sevenfold increase for V2R at the mRNA expression level in
cystic kidneys when compared with normal controls (Figure
9h and i).
DISCUSSION
In-frame deletion of Pkd1 results in a null allele
In this study, we report the creation of a new conventional
(Pkd1del2–6) and conditional (Pkd1flox) Pkd1-knockout mouse
model. The design of the targeting strategy allowed us to
create an in-frame deletion in the Pkd1 gene and to study the
effects of PC1 lacking the leucine-rich repeat, the WSC
homology domain, the first PKD domain, and the c-type
lectin-binding motif in the extracellular domain. It was
interesting to discover that an alternative splicing event in the
mutant transcript of the Pkd1del2–6 mice resulted in an mRNA
lacking exons 2–7 and a subsequent frame shift leading to a
stop codon early in exon 8, thus effectively creating a null
allele. This finding is of clinical significance, suggesting
‘in-frame deletions’ may function as inactivation mutations.
The PC1 protein was absent in the Pkd1del2–6 mouse kidneys,
which is consistent with the mRNA data.
Although both new Pkd1del2–6 and the previously pub-
lished Pkd1null9 mutations result in a null effect and the
absence of PC1 protein, the main difference between them is
the removal of the neo cassette in the Pkd1del2–6-mutant allele.
One striking phenotypic difference between homozygous
Pkd1del2–6 and Pkd1null mice that we observed was their
survival rate. Approximately 55% of the Pkd1del2–6 homo-
zygotes survived to term, although most died within hours
after birth, whereas the Pkd1null homozygotes rarely survived
beyond E18.5, as reported previously.9 Only four of 143
Pkd1null homozygotes in the C57/B6 genetic background
survived to term, but died immediately after birth. Most
Pkd1null homozygous embryos with a C57BL/6–129 mixed
background, identical to Pkd1del2–6, succumbed by E17.5.9
Pkd1del2–6 and Pkd1null kidneys both appear to be phenoty-
pically normal until E15.5, when cysts first arise. Aside from
the renal phenotype, Pkd1del2–6 mice develop pancreatic cystic
disease, as well as gross edema, as reported previously for
Pkd1null mice.9 However, the observed phenotype in
Pkd1del2–6 seems to be slightly milder than that observed
in Pkd1null mice likely contributing to the increased survival
observed in the former. The insertion of a neomycin
resistance cassette in exon 4 of the Pkd1null mutants may
have an impact on the genomic structure different from the
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deletion of exons 2–6 in the Pkd1del2–6 mutants, which may
contribute to the increased survival of Pkd1del2–6. We did not
observe any abnormality in the left–right body axis
determination in all 41 Pkd1del2–6 homozygous embryos
examined (out of a total of 323 pups in 46 litters). In
Pkd1del2–6/þ mice 8–21 months old, we observed sporadic
macroscopic liver and kidney cysts.
A new ADPKD mouse model by somatic inactivation of the
normal Pkd1 allele
In 1992, Reeders4 proposed a two-hit hypothesis as the
mechanism of cystogenesis for sporadic distribution of cysts
observed in ADPKD, and experimental evidence in human
tissues has supported this notion.5,6 To study the effect of
somatic inactivation of the Pkd1 allele in an animal
heterozygous for a Pkd1null mutation, we generated a
compound heterozygous Pkd1-knockout mouse,
gGt.Cre:Pkd1null/flox. Characterization of this model clearly
demonstrated that somatic inactivation of the second
(normal) Pkd1 allele causes cystogenesis, in accordance with
the two-hit hypothesis. The massive cystogenesis in
gGt.Cre:Pkd1null/flox mice, as compared with the very mild
phenotype in Pkd1del2–6/þ mice and other reported hetero-
zygous phenotype in Pkd1 mutants, can be attributed to the
much higher rate of second hits due to the presence of a Cre
transgene and the inactivation of the second Pkd1 allele due
to the recombination of the loxP sites rather than awaiting
spontaneous events. Recently, Piontek et al.15 reported the
creation of a conditional Pkd1-knockout model in which
somatic inactivation of Pkd1 was achieved by Cre expression
under an mouse mammary tumor virus (MMTV) promoter.
However, cysts developed and progressed very slowly. Very
few renal cysts formed in mice older than 2.5 months,15
probably because of a mosaic low level of expression of Cre
recombinase. The very sporadic cyst formation and slow
progression, although mimicking the ADPKD phenotype,
makes this model less desirable for the study of cystogenesis.
In the gGt-driven model discussed in this study, we report
massive and rapidly progressing cystogenesis in postnatal
animals, which would be a very useful tool for further studies
of polycystin function and ADPKD.
A notable observation during characterization of the
gGt.Cre:Pkd1null/flox phenotype was that the larger cysts
appeared to be primarily located in the renal medulla,
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Figure 9 | Increased cAMP levels correlate with cystic disease progression in cGt.Cre:Pkd1flox/flox mice. Co-staining for either LTA (a, c)
or DBA (d, f) with AQP2 (b, c, e, f) shows predominantly apical presence of AQP2 in cysts of distal origin in P5 mice. Arrows indicate AQP2 in
cysts, arrowheads indicate AQP2 in normal-looking tubules. (blue, DAPI; original magnification  100). (g) Direct measurement of cellular
cAMP shows massive increase in cystic kidneys versus normal controls. (h, i) Real-time PCR showing large increase of both V2R (h) and AQP2
(i) mRNA in cystic kidneys of P19 gGt.Cre:Pkd1flox/flox mice.
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indicating a more distal origin. gGt.Cre was previously reported
to be expressed in renal cortex, which mostly consists of
proximal tubules.19 This study identified a broader expression
pattern for gGt.Cre, which raises several new questions. Is
gGt.Cre expressed developmentally in common tubule pro-
genitor cells that later develop into distinct tubular segments?
Timed pregnancies using DsRed-reporter mice showed no
evidence of gGt.Cre expression at E15.5 (data not shown),
suggesting this is not a likely possibility. A more favorable
explanation is that gGt.Cre is expressed in distal tubule
segments at a low level as only four Cre molecules are necessary
for the excision of the floxed fragment.21,22 The use of DsRed-
reporter mice in conjunction with DBA, a collecting-duct
marker, revealed the presence of Cre recombinase in distal
segment derived cyst-lining epithelia, which indicates that the
gGt promoter fragment was indeed active in distal nephron
segments. Staining with other tubular markers, such as THP,
further confirmed this observation, suggesting that this model
is of close resemblance to human ADPKD in which cysts are of
both distal and proximal tubule origin.23
Another interesting observation is that some cysts
are positive for THP, DBA, and LTA markers in gGt.Cre:
Pkd1flox/flox animals under postnatal 2 weeks of age. In wild-
type animals, this is only observed in embryonic kidneys.
Because expression of multiple tubular segmental markers
was not seen in older gGt.Cre:Pkd1flox/flox animals, these
findings suggest a delay in the maturation of tubular
epithelial cells in polycystic kidneys. Expression of the
mesenchymal marker smooth-muscle actin in DBA- and
THP-positive cysts supports this hypothesis (Figure S1).
Potential mechanisms for a faster growth rate in cysts
derived from distal nephron segments
Cysts of distal tubule origin always appeared to be larger than
those derived from proximal tubules, which is similar to what
is observed in end-stage ADPKD kidneys in humans. We
therefore investigated the possible relationship between cyst
progression and tubular origins in time. Surprisingly, we
found that at early stages (p4 days), distal tubule cysts are,
on average, already four times larger than their proximal
counterparts. At late stages, the size ratio between DBA:LTA
cysts increased up to 70-fold. Is the faster growth rate of
distal cysts due to an increase in apoptosis in proximal versus
distal nephron segments, or a higher rate of cell proliferation
in the distal tubules? Although we observed enhanced
apoptosis in gGt.Cre:Pkd1flox/flox mouse kidneys, when
compared with controls, by TUNEL and Casp3 staining,
which label fragmented DNA in apoptotic cells and cells
committed to apoptosis, respectively, we did not see any
difference in cell death rate between cysts of proximal or
distal tubule origin. In contrast, by proliferating-cell nuclear
antigen staining, we observed a higher rate of proliferation in
distal nephron segments when compared with proximal
segments, which suggests that increased proliferation con-
tributes to the more rapid growth of distal cysts in
gGt.Cre:Pkd1flox/flox mouse kidneys.
It is interesting to note that distal segments (positive for
DBA) and medullary nephron segments seem to have a
higher proliferation rate than proximal tubules in normal
early postnatal kidneys (Figure 8). Moreover, the size of
proximal tubule cysts ceased to increase from postnatal day
12–15 (Figure 6), which coincides with the completion of
development and maturation of the normal kidney. After this
time, the proximal tubule cysts were significantly smaller,
which may be an indication of a non-essential role of PC1 in
this nephron segment from this stage onwards. This notion is
supported by our previous finding that expression of PC1 in
the kidney decreases drastically after postnatal 2 weeks.24
Particularly, proximal tubule expression of PC1 became
nearly undetectable in mature kidneys.25 In the context of the
‘flow hypothesis’, microvilli have been proposed to act as flow
sensors in the proximal tubules,26 which could compensate
for the loss of Pkd1 as a flow sensor.2 The distal tubules lack
this ameliorating system, indicating that Pkd1 might have a
critical role in the maintenance of tubule diameter in distal
tubules. Alternatively, the interstitial spaces adjacent to distal
tubules might be more prone to alteration or injury than
those adjacent to proximal tubules.27
Increased intracellular cAMP level has been seen in human
end-stage ADPKD kidneys and may play an important role in
cyst progression.28–32 Since camp-responsive proteins, such as
V2R and AQP2, are exclusively present in the distal segments
of the kidney and increased water secretion could contribute
to the faster growth rate of distal cysts. Therefore, we
determined the localization of AQP2 in gGt.Cre:Pkd1flox/flox
mutants. As expected, AQP2 translocated to the apical
membrane in distal cysts labeled by DBA, although remain-
ing in its intracellular location in normal-looking tubules as
shown in Figure 9. We also determined the mRNA expression
levels in cystic kidneys for AQP2 and V2R, and observed a 5-
and 7-fold increase, respectively. Direct measurements of
cellular cAMP levels in gGt.Cre:Pkd1flox/flox and their normal
littermates detected a 420-fold increase in cystic kidneys,
thus providing the first conclusive evidence for an increase of
cAMP in a Pkd1-disease model and its potential contribution
to cyst enlargement.
In summary, the rapidly progressing polycystic kidney
phenotype in our gGt.Cre:Pkd1null/flox and gGt.Cre:
Pkd1flox/flox mutants, with its massive cystogenesis at an early
age, but without negative effects on embryonic development,
provides us with an excellent animal model for studies of
pathogenesis and intervention of ADPKD.
MATERIALS AND METHODS
Generation of the Pkd1-targeting construct and chimeric
mice
A neomycin selection cassette flanked by two loxP sites was inserted
into the EcoRI site, located 1.2 kb upstream of exon 2. A third loxP
site was inserted into intron 6. All three loxP sites in the targeting
vector are in a direct repeat configuration. Chimeric mice were
generated by transfecting embryonic stem cells (E14, 129/sv
background) with the targeting vector, and homologous recombi-
nants were identified by PCR and Southern blot analysis using a
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50 probe, consisting of a 1-kb PCR fragment locatedB1 kb upstream
of the AvrII restriction site between exon 1 and 2 (Figure 1a, probe
A). Two independently targeted embryonic stem cell clones were
injected into C57BL/6J blastocysts to generate chimeric mice.
Chimeric mice were identified by contribution of the embryonic
stem cells to coat color (agouti) and were bred with wild-type
C57BL/6 mice to demonstrate germline transmission. DsRed mice
(STOCK Tg(ACTB-DsRed.MST)1Nagy/J) were obtained from
Jackson Laboratories (Bar Harbor, ME, USA).
Primers used
Recombination PCR was performed with the following primers:
exon 1-forward (KO-F): cgagtctgcgcatcc; exon 9-reverse (R104):
caggctcttcaagcttctgg; exon 2-forward (F27): cttcagacgctggacatag;
exon5-reverse, (R37): ttgcttctacttgcacctctg; exon 10-forward
(F201): tgtgtgcctgaggaactctg; exon 11-reverse (R201): ccaggggacactg
taggaga; ‘Flox’ PCR was performed with the following primers:
LoxP-forward (mPKD1loxpin6): acattatacgaagttatcatatgcttg; WT-
forward (mPKD1in6Spe2): gtcctgctgacaggactagttctt; intron 7-reverse
(mPKD1WTR1): cccctctcatcttgtttcctc; Cre-PCR was performed with
the following primers: gGT.Cre-forward (PST-N10-F): cttctccagtcc
ccctctgttgttt; gGT.Cre-reverse (PST-N10-R): ccgcgcgcctgaagatatagaa.
(Reverse transcriptase-)PCR conditions
Total RNA was harvested from kidney tissues using TrizolTM
(Invitrogen, Carlsbad, CA, USA) according to the supplier’s
protocol. RNA quality and concentration were assayed using agarose
gel electrophoresis and UV spectrophotometry (A260/A280). A 5-mg
weight of total RNA was reverse transcribed using SuperscriptTM II
reverse transcriptase (Invitrogen) in the presence of RNAseOUTTM
ribonuclease inhibitor (Invitrogen).
Reverse transcription reactions were performed according to the
manufacturer’s protocol (Invitrogen). Basic PCR conditions were as
follows: (1) 94 1C, 4 min; (2) 94 1C, 1 min; (3) 60 1C, x min; (4)
72 1C, 1 min; and (5) 72 1C, 10 min. Where x depends on the
expected product length (generally 1 min kb1) and steps 2–4 are
repeated for 30–35 cycles on a PTC-200 thermal cycler (MJ Research,
Waltham, MA, USA).
Real-time PCR
Samples were prepared using the Quantitect SYBR green kit
(Qiagen, Valencia, CA, USA) according to the manufacturer’s
protocol and semi-quantitative real-time PCR for AQP2 and V2R
was performed with a Lightcycler 1 (Roche, Nutley, NJ, USA) with
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as internal
control. The following primer sets for mouse Aqp2 (GenBank
NM009699), V2R (GenBank NM019404), and Gapdh (GenBank
M32599) were designed with Vector NTI advance software
(Invitrogen) using identical criteria: Aqp2: 50-ATGTGGGAA
CTCCGGTCCAT; 30-CAATCTGGAGCACAGAGGGTG; V2R: 50-AT
GATCCTGGTGTCTACCACGT; 30-ACTAACAGCGGGTCTCGGTC;
and Gapdh: 50-GATGCCCCCATGTTTGTGAT; 30-TTGTCATGGAT
GACCTTGGC.
Real-time PCR was performed using the following temperature
profile: denaturation: 95 1C for 15 min; cycling: melt 94 1C for 15 s;
annealing: 53 1C for 8 s; extension: 72 1C for 8 s.
Melting-curve analysis was performed after each run and data
were analyzed using Roche Lightcycler data analysis software
(v3.5.28). DCT values for Aqp2, V2R, and Gapdh were determined
using second-derivative analysis of the amplification curves. DCT for
Gapdh was used to normalize data (subtracting Gapdh DCT from
DCT for Aqp2 and V2R) and final results where expressed as a %
compared with control.
cAMP measurements
Kidneys from 19-day-old wild-type and CKO mice were harvested
and subsequently homogenized in 0.1 M HCl. Total cyclic was
measured in the resulting lysates using an enzymatic immunoassay
(Sigma, St Louis, MO, USA) according to the manufacturer’s
protocol. The assay is based on competition between unlabeled
cAMP and peroxidase-labeled cAMP for a limited number of sites
on an immobilized cAMP-specific antibody. The amount of
peroxidase-labeled ligand bound by the antibody is inversely
proportional to the concentration of unlabeled cAMP. Standard
curves were generated for each experiment.
Western blot analysis
Western blotting was performed as previously described.18 The
primary antibodies used included rabbit anti-PC2 polyclonal
antibody 96525,33 rabbit anti-PC1 polyclonal antibody 96521, rabbit
anti-p21 polyclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), rabbit anti-p27 polyclonal antibody (Santa Cruz
Biotechnology), and mouse anti-PC1 monoclonal antibody (7e12; a
kind gift from Dr C Ward). The secondary antibody used for
western blotting was goat anti-rabbit IgG–horseradish peroxidase or
goat-anti-mouse IgG–horseradish peroxidase, 1:10 000 dilution
(Amersham Biosciences, Pittsburgh, PA, USA).
Histology and immunocytochemistry
For histological studies, kidneys from study animals were hemi-
sected in either sagittal or cross-sectional plane, fixed in 10%
formalin, and embedded in paraffin. Sections were subsequently
stained with hematoxylin–eosin.9 Immunofluorescence was per-
formed as follows: formalin fixed, paraffin-embedded sections were
deparaffinized with xylene and subsequently rehydrated with a
graded series of alcohol solutions (100–30%). Antigen was retrieved
with a commercial antigen-retrieval solution (Vector Laboratories,
Burlingame, CA, USA) according to the manufacturer’s protocol.
Sections were blocked with 10% normal goat serum or 5% bovine
serum albumin in phosphate-buffered saline (Dako, Carpinteria,
CA, USA) for 30–60 min at room temperature.
Primary and secondary antibodies and/or lectins were applied
diluted in either 2% goat serum/phosphate-buffered saline or 1%
bovine serum albumin/phosphate-buffered saline, and incubated for
1 h at room temperature. Primary antibodies or lectins were used at
the following dilutions: rhodamine-coupled DBA (Vector Labora-
tories) at 1:50 dilution; fluorescein-coupled LTA (Vector Labora-
tories) at 1:500 dilution; goat anti-THP/uromucoid IgG (Cappel/
MP Biomedicals, Solon, OH, USA) at 1:100 dilution; mouse anti-
smooth-muscle actin (Sigma) at 1:200 dilution; goat anti-AQP2
(Santa Cruz Biotechnology) at 1:100 dilution; rabbit anti-cleaved
caspase3 (Cell Signaling, Danvers, MA, USA) at 1:400 dilution;
fluorescein isothiocyanate-coupled rabbit anti-RFP (ab34764;
Abcam, MA, USA) 1:500; Alexa 594-coupled donkey anti-mouse/
anti-rabbit IgG’s at 1:2000 dilutions. Sections were mounted in
VectashieldþDapi (Vector Laboratories). Epifluorescent images
were taken with a Nikon Eclipse TE2000-E inverted microscope
(Nikon, Melville, NJ, USA) equipped with a Photometrics Coolsnap
HQ camera (Photometrics, AZ) and background subtraction and
filtering were performed using Adobe Photoshop CS2 (Adobe
Systems Inc., San Jose, CA, USA).
1404 Kidney International (2008) 73, 1394–1405
o r i g i n a l a r t i c l e PG Starremans et al.: A conditional mouse model for polycystic kidney disease
TUNEL staining of formalin-fixed, paraffin-embedded tissue
sections was performed using the Apoptag, Peroxidase In Situ
apoptosis Detection kit (Chemicon, CA, USA) according to the
manufacturer’s protocol, and light-microscopic images were taken
with a Leica DMLS microscope (Leica Microsystems GmbH,
Nussloch, Germany) equipped with a Kodak DC290 camera (Kodak,
Rochester, NY, USA).
Digital analysis of cyst size
Paraffin sections were pretreated as described and subsequently
co-stained with DBA and LTA. Epifluorescent images were taken at a
total magnification of  100. At least four different fields per section
were photographed, and cyst number and cyst area were measured
using Image Pro Plus v5 software (Media Cybernetics, MD, USA),
and numerical data were subsequently processed in Microsoft Excel.
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SUPPLEMENTARY MATERIAL
Figure S1. Evidence of a delay or defect in kidney maturation in
gGt.Cre:Pkd1flox/flox mice.
Figure S2. Increased apoptosis occurs in cystic kidneys of
gGt.Cre:Pkd1flox/flox mice in time.
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